Reduced diffusing capacity of the lungs for carbon monoxide (DLco) reflects microvasculopathy in chronic thromboembolic ...
Findings from IMPALA-2 showed a statistically significant difference in precentage predicted DLCO between the molgramostim and placebo arms at week 24 and at week 48. Treatment with molgramostim ...
Pulmonary function tests are a group of noninvasive breathing tests that measure how much air your lungs can hold, how ...
A pair of studies presented at the European Respiratory Society Congress 2024 emphasized the importance of close monitoring and proactive treatment approaches for patients with idiopathic (IPF) and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback